Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 856,779 |
|
|||||
| News | - | ||||||
| Day High | 40.25 | Low High |
|||||
| Day Low | 38.40 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Vera Therapeutics Inc | VERA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.96 | 2.48% | 39.65 | 19:50:54 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 38.75 | 38.40 | 40.25 | 39.65 | 38.69 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 9,211 | 856,779 | $ 39.77 | $ 34,070,435 | - | 6.07 - 50.78 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:21:02 | 2 | $ 41.63 | USD |
Vera Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.76B | 44.43M | - | 0 | -95.99M | -2.16 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Vera Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VERA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 39.51 | 43.05 | 36.335 | 38.96 | 985,163 | 0.14 | 0.35% |
| 1 Month | 42.98 | 50.65 | 35.855 | 42.53 | 1,273,205 | -3.33 | -7.75% |
| 3 Months | 38.56 | 50.78 | 35.855 | 43.30 | 1,074,113 | 1.09 | 2.83% |
| 6 Months | 9.93 | 50.78 | 9.68 | 32.26 | 1,003,054 | 29.72 | 299.30% |
| 1 Year | 6.33 | 50.78 | 6.07 | 25.34 | 807,637 | 33.32 | 526.38% |
| 3 Years | 11.41 | 50.78 | 5.20 | 21.00 | 402,369 | 28.24 | 247.50% |
| 5 Years | 11.41 | 50.78 | 5.20 | 21.00 | 402,369 | 28.24 | 247.50% |
Vera Therapeutics Description
| Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases. |
